| Literature DB >> 34197362 |
Jonathan Bryant-Genevier, Carol Y Rao, Barbara Lopes-Cardozo, Ahoua Kone, Charles Rose, Isabel Thomas, Diana Orquiola, Ruth Lynfield, Dhara Shah, Lori Freeman, Scott Becker, Amber Williams, Deborah W Gould, Hope Tiesman, Geremy Lloyd, Laura Hill, Ramona Byrkit.
Abstract
Increases in mental health conditions have been documented among the general population and health care workers since the start of the COVID-19 pandemic (1-3). Public health workers might be at similar risk for negative mental health consequences because of the prolonged demand for responding to the pandemic and for implementing an unprecedented vaccination campaign. The extent of mental health conditions among public health workers during the COVID-19 pandemic, however, is uncertain. A 2014 survey estimated that there were nearly 250,000 state and local public health workers in the United States (4). To evaluate mental health conditions among these workers, a nonprobability-based online survey was conducted during March 29-April 16, 2021, to assess symptoms of depression, anxiety, post-traumatic stress disorder (PTSD), and suicidal ideation among public health workers in state, tribal, local, and territorial public health departments. Among 26,174 respondents, 53.0% reported symptoms of at least one mental health condition in the preceding 2 weeks, including depression (32.0%), anxiety (30.3%), PTSD (36.8%), or suicidal ideation (8.4%). The highest prevalence of symptoms of a mental health condition was among respondents aged ≤29 years (range = 13.6%-47.4%) and transgender or nonbinary persons (i.e., those who identified as neither male nor female) of all ages (range = 30.4%-65.5%). Public health workers who reported being unable to take time off from work were more likely to report adverse mental health symptoms. Severity of symptoms increased with increasing weekly work hours and percentage of work time dedicated to COVID-19 response activities. Implementing prevention and control practices that eliminate, reduce, and manage factors that cause or contribute to public health workers' poor mental health might improve mental health outcomes during emergencies.Entities:
Mesh:
Year: 2021 PMID: 34197362 PMCID: PMC8248597 DOI: 10.15585/mmwr.mm7026e1
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Mental health symptoms among 26,174 state, tribal, local, and territorial public health workers during the past 2 weeks, by demographic characteristics and work factors — United States, March–April 2021
| Characteristic | No. | Depression* (n = 23,112†) | Anxiety* (n = 23,610†) | PTSD* (n = 22,248†) | Suicidal ideation (n = 23,317†) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Prevalence, % | PR (95% CI) | Prevalence, % | PR (95% CI) | Prevalence, % | PR (95% CI) | Prevalence, % | PR (95% CI) | ||
| Overall | 26,174* | 32.0 | –– | 30.3 | –– | 36.8 | –– | 8.4 | –– |
|
| |||||||||
| ≤29 | 3,525 | 41.4 | 2.09 (1.92–2.28) | 44.7 | 2.81 (2.56–3.09) | 47.4 | 2.03 (1.88–2.19) | 13.6 | 2.98 (2.46–3.60) |
| 30–39 | 5,461 | 35.2 | 1.78 (1.63–1.93) | 37.1 | 2.33 (2.12–2.56) | 42.3 | 1.81 (1.68–1.95) | 10.3 | 2.26 (1.87–2.73) |
| 40–49 | 5,102 | 32.3 | 1.63 (1.50–1.78) | 29.1 | 1.83 (1.66–2.01) | 37.3 | 1.60 (1.48–1.73) | 7.5 | 1.65 (1.36–2.01) |
| 50–59 | 4,925 | 28.8 | 1.45 (1.33–1.59) | 23.5 | 1.47 (1.33–1.63) | 32.0 | 1.37 (1.26–1.48) | 6.0 | 1.32 (1.08–1.62) |
| ≥60 | 2,830 | 19.8 | Ref | 15.9 | Ref | 23.4 | Ref | 4.6 | Ref |
|
| |||||||||
| Male | 3,904 | 28.2 | Ref | 24.4 | Ref | 33.2 | Ref | 9.9 | Ref |
| Female | 19,873 | 32.3 | 1.15 (1.09–1.21) | 31.2 | 1.28 (1.20–1.36) | 37.2 | 1.12 (1.07–1.18) | 7.9 | 0.81 (0.72–0.90) |
| Transgender or nonbinary | 147 | 62.4 | 2.21 (1.93–2.54) | 61.1 | 2.21 (1.88–2.59) | 65.5 | 1.97 (1.74–2.24) | 30.4 | 3.10 (2.37–4.06) |
|
| |||||||||
| Hispanic | 1,974 | 31.4 | 0.97 (0.90–1.04) | 29.9 | 0.95 (0.89–1.02) | 37.5 | 1.01 (0.95–1.07) | 9.9 | 1.20 (1.03–1.39) |
| AI/AN, NH | 156 | 36.8 | 1.14 (0.92–1.40) | 32.7 | 1.04 (0.83–1.31) | 41.6 | 1.12 (0.92–1.35) | 7.3 | 0.89 (0.50–1.57) |
| Asian, NH | 1,009 | 29.8 | 0.92 (0.83–1.02) | 27.6 | 0.88 (0.79–0.98) | 38.3 | 1.03 (0.94–1.12) | 10.1 | 1.22 (1.00–1.49) |
| Black, NH | 2,177 | 25.5 | 0.79 (0.73–0.85) | 21.7 | 0.69 (0.64–0.75) | 29.8 | 0.80 (0.75–0.86) | 6.5 | 0.79 (0.67–0.94) |
| NH/PI, NH | 96 | 28.2 | 0.87 (0.62–1.22) | 22.2 | 0.71 (0.48–1.04) | 25.3 | 0.68 (0.47–0.98) | 11.1 | 1.34 (0.75–2.42) |
| White, NH | 17,218 | 32.4 | Ref | 31.4 | Ref | 37.2 | Ref | 8.3 | Ref |
| Multiple races, NH | 614 | 40.7 | 1.26 (1.14–1.39) | 37.2 | 1.19 (1.07–1.32) | 43.4 | 1.17 (1.06–1.28) | 12.1 | 1.46 (1.17–1.83) |
|
| |||||||||
| Less than bachelor’s | 5,386 | 32.3 | Ref | 27.1 | Ref | 30.1 | Ref | 6.5 | Ref |
| Bachelor’s | 9,180 | 32.6 | 1.01 (0.96–1.06) | 30.6 | 1.13 (1.07–1.20) | 36.8 | 1.22 (1.16–1.29) | 9.1 | 1.40 (1.24–1.59) |
| Graduate | 9,375 | 31.2 | 0.97 (0.92–1.02) | 32.0 | 1.18 (1.12–1.25) | 40.7 | 1.35 (1.29–1.42) | 8.9 | 1.37 (1.22–1.56) |
|
| |||||||||
| ≤40 | 9,993 | 24.8 | Ref | 24.4 | Ref | 27.3 | Ref | 7.6 | Ref |
| 41–60 | 11,466 | 34.3 | 1.38 (1.33–1.45) | 32.3 | 1.32 (1.26–1.38) | 40.4 | 1.48 (1.42–1.54) | 8.4 | 1.10 (1.00–1.21) |
| >60 | 3,018 | 46.6 | 1.88 (1.79–1.98) | 41.6 | 1.70 (1.61–1.80) | 54.2 | 1.99 (1.89–2.08) | 11.0 | 1.44 (1.27–1.63) |
|
| |||||||||
| None | 1,787 | 23.6 | Ref | 23.0 | Ref | 22.3 | Ref | 7.6 | Ref |
| 1–25 | 5,151 | 24.9 | 1.06 (0.96–1.17) | 23.5 | 1.02 (0.92–1.13) | 24.3 | 1.09 (0.98–1.21) | 7.5 | 0.99 (0.82–1.21) |
| 26–50 | 3,432 | 28.9 | 1.23 (1.11–1.36) | 26.7 | 1.16 (1.05–1.29) | 31.6 | 1.42 (1.28–1.57) | 8.4 | 1.12 (0.91–1.37) |
| 51–75 | 3,283 | 31.6 | 1.34 (1.21–1.48) | 30.6 | 1.33 (1.20–1.47) | 37.0 | 1.66 (1.50–1.84) | 8.6 | 1.14 (0.93–1.40) |
| ≥76 | 10,620 | 37.9 | 1.61 (1.47–1.76) | 35.9 | 1.56 (1.42–1.71) | 47.0 | 2.11 (1.92–2.32) | 8.9 | 1.18 (0.99–1.41) |
|
| |||||||||
| Yes | 13,507 | 23.5 | Ref | 23.0 | Ref | 27.9 | Ref | 6.2 | Ref |
| No | 8,586 | 45.3 | 1.93 (1.85–2.00) | 42.4 | 1.85 (1.77–1.92) | 51.5 | 1.84 (1.78–1.91) | 12.0 | 1.92 (1.76–2.10) |
Abbreviations: AI/AN = American Indian or Alaska Native; CI = confidence interval; IES-6 = 6-item Impact of Event Scale; GAD-2 = General Anxiety Disorder; NH = non-Hispanic; NH/PI = Native Hawaiian or Pacific Islander; PHQ-9 = 9-item Patient Health Questionnaire; PR = prevalence ratio; PTSD = post-traumatic stress disorder; Ref = referent group.
* Symptoms of mental health conditions were scored and categorized by severity. Respondents who scored ≥10.0 out of 27 on the PHQ-9 for depression, ≥3.0 out of 6 on the GAD-2 for anxiety, or ≥1.75 out of 4 on the IES-6 for PTSD were considered symptomatic for the respective conditions. Respondents who indicated that they would be better off dead or thought of hurting themselves at any time in the past 2 weeks were categorized as experiencing suicidal ideation.
† Some categories might not sum to 26,174 because of missing data. Denominators for categories are respondents who answered the questions to be scored.
FIGUREDistribution* of 9-item Patient Health Questionnaire scores for depression and 6-item Impact of Event Scale scores for post-traumatic stress disorder among state, tribal, local, and territorial public health worker respondents, by percentage of work time spent directly on COVID-19 response activities for the majority of 2020 (panels A, C), and hours worked in a typical week since March 2020 (panels B, D) — United States, March–April 2021
Abbreviations: IES-6 = 6-item Impact of Event Scale; PHQ-9 = 9-item Patient Health Questionnaire; PTSD = post-traumatic stress disorder.
* Upper and lower levels of boxes indicate 75th and 25th percentiles, respectively; horizontal line indicates median; whiskers indicate observation nearest to 1.5 × interquartile range.
† Self-reported symptoms of depression or PTSD were evaluated; respondents who scored ≥10.0 out of 27 on the PHQ-9 for depression or ≥1.75 out of 4 on the IES-6 for PTSD were considered symptomatic for the respective conditions.
§ Only public health worker respondents who completed all PHQ-9 items (n = 23,112) or all IES-6 items (n = 22,248) are included.
Traumatic events or stressors reported by 26,174 state, tribal, local, and territorial public health workers and comparisons* of symptoms of post-traumatic stress disorder — United States, March–April 2021
| Traumatic event or stressor/Response | No.§ | PTSD prevalence, % | PTSD PR (95% CI) |
|---|---|---|---|
|
| |||
|
| |||
| Yes¶ | 2,834 | 36.7 | 1.03 (0.98–1.09) |
| Maybe** | 3,310 | 42.4 | 1.19 (1.14–1.25) |
| No | 16,266 | 35.6 | Ref |
|
| |||
| Yes | 747 | 49.6 | 1.36 (1.27–1.47) |
| No | 22,084 | 36.3 | Ref |
|
| |||
| Yes | 7,580 | 42.3 | 1.24 (1.20–1.29) |
| No | 15,403 | 34.0 | Ref |
|
| |||
| Yes | 20,857 | 39.4 | 3.11 (2.77–3.48) |
| No | 2,203 | 12.7 | Ref |
|
| |||
| Yes | 12,944 | 49.8 | 2.49 (2.38–2.60) |
| No | 10,080 | 20.0 | Ref |
|
| |||
|
| |||
| Yes | 16,563 | 45.4 | 3.10 (2.91–3.30) |
| No | 6,451 | 14.7 | Ref |
|
| |||
| Yes | 14,051 | 49.0 | 2.77 (2.64–2.91) |
| No | 8,964 | 17.7 | Ref |
|
| |||
| Yes | 13,703 | 45.2 | 1.85 (1.78–1.93) |
| No | 9,101 | 24.4 | Ref |
|
| |||
| Yes | 12,362 | 46.5 | 1.82 (1.76–1.90) |
| No | 10,551 | 25.5 | Ref |
|
| |||
| Yes | 5,962 | 56.2 | 1.88 (1.82–1.94) |
| No | 16,944 | 29.9 | Ref |
|
| |||
| Yes | 2,699 | 61.8 | 1.85 (1.78–1.92) |
| No | 20,262 | 33.4 | Ref |
|
| |||
| Yes | 5,376 | 59.0 | 1.97 (1.91–2.03) |
| No | 17,594 | 30.0 | Ref |
|
| |||
| Yes | 11,143 | 41.1 | 1.23 (1.19–1.28) |
| No | 13,318 | 33.3 | Ref |
|
| |||
| Yes | 11,197 | 42.6 | 1.36 (1.31–1.41) |
| No | 11,805 | 31.3 | Ref |
Abbreviations: IES-6 = 6-item Impact of Event Scale; PR = prevalence ratio; PTSD = post-traumatic stress disorder; Ref = referent group.
* Referent group for all prevalence ratio calculations was not experiencing the traumatic event/stressor (i.e., “No” category).
† Experienced symptoms of post-traumatic stress disorder in the 2 weeks preceding survey, defined as having an IES-6 score ≥1.75 out of 4.
§ Some categories might not sum to 26,174; only those respondents who completed IES-6 questions (N = 22,248) are included in analysis.
¶ Positive COVID-19 test or diagnosis by medical professional.
** Had symptoms compatible with COVID-19 but not tested or test inconclusive.